ACTG Publications

TitleAuthorsDateJournalIssueVolume
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.Moore, Carrie B ; Verma, Anurag ; Pendergrass, Sarah ; Verma, Shefali S ; Johnson, Daniel H ; Daar, Eric S ; Gulick, Roy M ; Haubrich, Richard ; Robbins, Gregory K ; Ritchie, Marylyn D ; Haas, David W2015 JanOpen Forum Infect Dis12
Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events.Haas, David W ; Bradford, Yuki ; Verma, Anurag ; Verma, Shefali S ; Eron, Joseph J ; Gulick, Roy M ; Riddler, Sharon A ; Sax, Paul E ; Daar, Eric S ; Morse, Gene D ; Acosta, Edward P ; Ritchie, Marylyn D2018 JulPharmacogenet Genomics728
PHENOME-WIDE INTERACTION STUDY (PheWIS) IN AIDS CLINICAL TRIALS GROUP DATA (ACTG).Verma, Shefali S ; Frase, Alex T ; Verma, Anurag ; Pendergrass, Sarah A ; Mahony, Shaun ; Haas, David W ; Ritchie, Marylyn D2016Pac Symp Biocomput21
Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression.Li, Binglan ; Verma, Shefali S ; Veturi, Yogasudha C ; Verma, Anurag ; Bradford, Yuki ; Haas, David W ; Ritchie, Marylyn D2018Pac Symp Biocomput23
European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142.Hulgan, Todd ; Haubrich, Richard ; Riddler, Sharon A ; Tebas, Pablo ; Ritchie, Marylyn D ; McComsey, Grace A ; Haas, David W ; Canter, Jeffrey A2011 Jan 2AIDS125
Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384.Grady, Benjamin J ; Samuels, David C ; Robbins, Gregory K ; Selph, Doug ; Canter, Jeffrey A ; Pollard, Richard B ; Haas, David W ; Shafer, Robert ; Kalams, Spyros A ; Murdock, Deborah G ; Ritchie, Marylyn D ; Hulgan, Todd ; ACTG 384 and DACS 250 Study Teams2011 Dec 1J Acquir Immune Defic Syndr458
Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study.Motsinger, Alison A ; Ritchie, Marylyn D ; Shafer, Robert W ; Robbins, Gregory K ; Morse, Gene D ; Labbe, Line ; Wilkinson, Grant R ; Clifford, David B ; D'Aquila, Richard T ; Johnson, Victoria A ; Pollard, Richard B ; Merigan, Thomas C ; Hirsch, Martin S ; Donahue, John P ; Kim, Richard B ; Haas, David W2006 NovPharmacogenet Genomics1116
Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202.Verma, Anurag ; Bradford, Yuki ; Verma, Shefali S ; Pendergrass, Sarah A ; Daar, Eric S ; Venuto, Charles ; Morse, Gene D ; Ritchie, Marylyn D ; Haas, David W2017 MarPharmacogenet Genomics327
Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202.Johnson, Daniel H ; Venuto, Charles ; Ritchie, Marylyn D ; Morse, Gene D ; Daar, Eric S ; McLaren, Paul J ; Haas, David W2014 AprPharmacogenet Genomics424
Mitochondrial DNA variation and changes in adiponectin and endothelial function in HIV-infected adults after antiretroviral therapy initiation.Hulgan, Todd ; Stein, James H ; Cotter, Bruno R ; Murdock, Deborah G ; Ritchie, Marylyn D ; Dubé, Michael P ; Gerschenson, Mariana ; Haas, David W ; Torriani, Francesca J ; Aids Clinical Trials Group A5152s And Dacs 252 Study Teams2013 OctAIDS Res Hum Retroviruses1029
African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapy.Canter, Jeffrey A ; Robbins, Gregory K ; Selph, Doug ; Clifford, David B ; Kallianpur, Asha R ; Shafer, Robert ; Levy, Shawn ; Murdock, Deborah G ; Ritchie, Marylyn D ; Haas, David W ; Hulgan, Todd ; AIDS Clinical Trials Group Study 384 Team ; New Work Concept Sheet 273 Team2010 Jun 1J Infect Dis11201
Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy.Kallianpur, Asha R ; Hulgan, Todd ; Canter, Jeffrey A ; Ritchie, Marylyn D ; Haines, Jonathan L ; Robbins, Gregory K ; Shafer, Robert W ; Clifford, David B ; Haas, David W2006 Jul 13AIDS1120
Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study.Haas, David W ; Geraghty, Daniel E ; Andersen, Janet ; Mar, Jessica ; Motsinger, Alison A ; D'Aquila, Richard T ; Unutmaz, Derya ; Benson, Constance A ; Ritchie, Marylyn D ; Landay, Alan ; AIDS Clinical Trials Group2006 Oct 15J Infect Dis8194
Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study.Ribaudo, Heather J ; Liu, Huan ; Schwab, Matthias ; Schaeffeler, Elke ; Eichelbaum, Michel ; Motsinger-Reif, Alison A ; Ritchie, Marylyn D ; Zanger, Ulrich M ; Acosta, Edward P ; Morse, Gene D ; Gulick, Roy M ; Robbins, Gregory K ; Clifford, David ; Haas, David W2010 Sep 1J Infect Dis5202
Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants.Holzinger, Emily R ; Grady, Benjamin ; Ritchie, Marylyn D ; Ribaudo, Heather J ; Acosta, Edward P ; Morse, Gene D ; Gulick, Roy M ; Robbins, Gregory K ; Clifford, David B ; Daar, Eric S ; McLaren, Paul ; Haas, David W2012 DecPharmacogenet Genomics1222
Use of biological knowledge to inform the analysis of gene-gene interactions involved in modulating virologic failure with efavirenz-containing treatment regimens in ART-naïve ACTG clinical trials participants.Grady, Benjamin J ; Torstenson, Eric S ; McLaren, Paul J ; DE Bakker, Paul I W ; Haas, David W ; Robbins, Gregory K ; Gulick, Roy M ; Haubrich, Richard ; Ribaudo, Heather ; Ritchie, Marylyn D2011Pac Symp Biocomput